EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Amelioration of diabetic autonomic neuropathy symptoms following a course of transcranial direct current stimulation

Roghayeh Mohammadi, Ahmad Alipour

Brain Communications · 2026-10-31 · 8 (6)

DOI: 10.1093/braincomms/fcag406 ↗
AbstractBibliografische Angaben

Abstract

Abstract Cardiovascular autonomic neuropathy (CAN) is a severe and potentially life-threatening complication of diabetes. This randomized, sham-controlled, three-arm trial evaluated the efficacy of anodal transcranial direct current stimulation (tDCS) targeting the left dorsolateral prefrontal cortex for improving CAN symptoms and glycaemic control in older patients with insulin-dependent diabetes. Seventy-two participants (aged 60–80 years) with symptomatic CAN were randomly allocated to active tDCS (n = 24), sham tDCS (n = 24) or routine care only (control group, n = 24). The primary outcome was CAN severity quantified by the ratio of the change in systolic blood pressure to the change in heart rate measured three minutes after standing from a supine position; the secondary outcome was long-term glycaemic control assessed by glycated haemoglobin. The active and sham groups received 30 sessions of tDCS (2 milliamperes for 20 min per session, anode at F3 and cathode at Fp2) over 6–8 weeks. Outcomes were assessed at baseline, post-intervention, and one-month follow-up. Data were analysed with mixed-design ANOVA. A significant Time × Group interaction was found for CAN severity (P < 0.001, partial eta squared = 0.165). The active tDCS group demonstrated significantly greater improvement in CAN symptoms from baseline to post-intervention compared with both the sham tDCS and control groups (P < 0.001), with these improvements remaining evident at one-month follow-up despite a small, non-significant numerical increase from post-intervention. The active tDCS group also achieved superior glycaemic control at follow-up (mean glycated haemoglobin 7.92 ± 0.79%) relative to the sham group (8.78 ± 1.05%, P = 0.008) and control group (9.12 ± 1.18%, P = 0.001). Thirty sessions of left dorsolateral prefrontal cortex anodal tDCS was safe and well-tolerated. These findings indicate that left dorsolateral prefrontal cortex tDCS can improve cardiovascular autonomic function and glycaemic control in older adults with diabetic CAN and warrant larger, longer-term, multi-centre randomized controlled trials to confirm efficacy, durability and generalizability.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →